Paratek Pharmaceuticals, Inc. Uncategorized Contracts & Agreements

47 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Contingent Value Rights Agreement to be entered into between Resistance Acquisition, Inc. and a Rights Agent
Paratek Pharmaceuticals, Inc.
2023
Amendment No. 4 to the Product Agreement, by and between the Company and Patheon UK Limited, dated as of November 17, 2021
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
2022
Paratek Pharmaceuticals, Inc. 2017 Inducement Plan, as amended
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
DE
2022
Amendment No. 3 to the Product Agreement, by and between the Company and Patheon UK Limited, dated as of July 1, 2020
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
2021
Amendment No. 2 to the Product Agreement, by and between the Company and Patheon UK Limited, dated as of June 1, 2019
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
2021
Description of Securities
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020
Amended and Restated Employee Agreement for Adam Woodrow effective June 25, 2019
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
PA
2019
Amended and Restated Employee Agreement for Evan Loh, MD, effective June 25, 2019
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
PA
2019
Amended and Restated Employee Agreement for Michael F. Bigham effective June 25, 2019
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
MA
2019
Amendment Agreement - Amendment No. 1 to Patheon Product Agreement by and between the Company and Patheon UK Limited dated as of January 1, 2019
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
2019
First Amendment of Outsourcing Agreement, by and between the Company and CARBOGEN AMCIS AG, dated as of December 18, 2018
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
2019
Paratek Pharmaceuticals, Inc. 2017 Inducement Plan, as amended
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
PARATEK PHARMACEUTICALS, INC. 2017 INDUCEMENT PLAN ADOPTED: June 15, 2017
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
DE
2017
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST.REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES...
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
MA
2017
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST.REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES...
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
2017
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST.REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES...
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
MA
2017
Relocation Expense
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
MA
2015
PARATEK PHARMACEUTICALS, INC. AMENDMENT NO. 1 TO TAXBENEFIT PRESERVATION PLAN
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
DE
2015
[remainder of page intentionally left blank]
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
MA
2015
[remainder of page intentionally left blank]
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
MA
2015
[remainder of page intentionallyleft blank]
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
MA
2015
PARATEK PHARMACEUTICALS, INC. 2015 INDUCEMENT PLAN ADOPTED: FEBRUARY 4, 2015
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
DE
2015
FIFTH AMENDMENT (1003 West Cutting Boulevard, Richmond, California)
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
2014
SUPPORT AGREEMENT
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
DE
2014
SUPPORT AGREEMENT
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
DE
2014
TRANSCEPT PHARMACEUTICALS, INC. and AMERICAN STOCKTRANSFER & TRUST COMPANY, LLC as Rights Agent Tax Benefit Preservation Plan Dated as of September 13, 2013 TAX BENEFIT...
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
DE
2013
AMENDMENT #2 TO
Paratek Pharmaceuticals, Inc.
2009
AMENDMENT #1 TO
Paratek Pharmaceuticals, Inc.
2009
LP Clover Limited
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
2009
Purdue Pharmaceutical Products L.P. One Stamford Forum Stamford, CT 06901
Paratek Pharmaceuticals, Inc.
2009
TRANSCEPT PHARMACEUTICALS, INC. Amended and Restated Independent Director Cash CompensationPolicy
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
2009
TRANSORAL PHARMACEUTICALS, INC.
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
CA
2009
TRANSCEPTPHARMACEUTICALS, INC.
Paratek Pharmaceuticals, Inc.
2009
ANDREORGANIZATION among: NOVACEA, INC., a Delaware corporation;
Paratek Pharmaceuticals, Inc.
2008
NOVACEA, INC. September 19, 2007
Paratek Pharmaceuticals, Inc.
2007
19 April 2007 (1) BTG INTERNATIONAL LIMITED
Paratek Pharmaceuticals, Inc.
2007
Novacea, Inc.
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
2006
NOVACEA, INC.
Paratek Pharmaceuticals, Inc.
2006
Shares
Paratek Pharmaceuticals, Inc.
2006
NOVACEA, INC.
Paratek Pharmaceuticals, Inc.
2006